0366U CPT® code: payer coverage and prior authorization0366U appears in 7 coverage policies from Aetna, Blue Cross & Blue Shield of Mississippi, Blue Cross & Blue Shield of Rhode Island, Blue Cross NC, Blue Shield of California, Premera Blue Cross, Regence.
| Payer | Policy | Role in policy | Reviewed | Document |
|---|---|---|---|---|
| Aetna | Tumor Markers (0352) | not covered | Aug 25, 2026 | payer document |
| Blue Cross & Blue Shield of Mississippi | Urinary Biomarkers For Cancer Screening Diagnosis And Surveillance | unproven / investigational | payer document | |
| Blue Cross & Blue Shield of Rhode Island | Laboratory Testing Investigational Services MEDICAL COVERAGE POLICY | 3 | not covered | Jan 7, 2026 | payer document |
| Blue Cross NC | Urinary Tumor Markers for Bladder Cancer AHS - G2125 | listed, no stance | Apr 1, 2026 | payer document |
| Blue Shield of California | Laboratory Testing Investigational Services (2.04.159) | listed, no stance | payer document | |
| Premera Blue Cross | Laboratory Testing Investigational Services (2.04.520) Page | 5 of 21 | ∞ | unproven / investigational | Oct 1, 2026 | payer document |
| Regence | Urinary Biomarkers for Cancer Screening, Diagnosis, and Surveillance (Laboratory 72) | listed, no stance | Dec 1, 2025 | payer document |
Prior authorization required or conditional in IN, MS.
From payers' published prior-auth lists, coverage policies and state Medicaid fee schedules, updated Oct 16, 2026. The role is what the policy's own code table or text says about the code. Not a guarantee of coverage or payment; verify with the payer. CPT® is a registered trademark of the American Medical Association.